Randomized Trial Shows Tandem CAR T Therapy Extends Event-Free Survival in Older Lymphoma Population 6 days ago AnaIn BreakthroughsClinical TrialsResearch Updates
Analysis: Type VI Retrons Offer a New Molecular Switch, Not a Ready-Made Therapy 1 week ago AnaIn AI & DataFeatured AnalysisLeadersTechnology
Alligator Sells Mitazalimab to Biossil in Upfront and Contingent Deal 1 week ago AnaIn Biopharma HighlightsBreaking NewsDealsTop Stories
Analysis: X4 Builds a Two-Trial Case for Mavorixafor in Chronic Neutropenia 1 week ago AnaIn AI & DataClinical TrialsFeatured AnalysisPharma Industry Updates
Sobi Phase 3 Gout Drug Hits Serum Urate Target Through 12 Months 1 week ago AnaIn BreakthroughsClinical TrialsResearch UpdatesTop Stories
Lilly Retatrutide Beats Ozempic on A1C and Weight in Head-to-Head Phase 3 Diabetes Trial 1 week ago AnaIn AI & DataBiopharma HighlightsBreaking NewsClinical TrialsTop Stories
Analysis: TCG Labs Soleil Tests Whether a Shared Research Engine Can Build Multiple Clinical Companies Efficiently 1 week ago AnaIn AI & DataFeatured AnalysisInvestmentsStartupsVenture Capital
Benitec Reports All Nine Treated Patients Responded to BB-301 Gene Therapy in Rare Muscle Disease Study 1 week ago AnaIn BreakthroughsClinical TrialsResearch UpdatesTop Stories
Coherus Reports 75 Percent Confirmed Response Rate for Tagmokitug Regimen in First-Line Esophageal Cancer 2 weeks ago AnaIn Biopharma HighlightsClinical TrialsInnovationResearch Updates
IGC Pharma Builds Regulatory and Data Team Ahead of CALMA Phase 2 Readout 3 months ago AnaIn AI & DataClinical TrialsPharma Industry UpdatesResearch UpdatesTechnology
Neuronetics Q2 Update Tests the Scale Economics of Interventional Psychiatry 3 months ago AnaIn Featured AnalysisInnovationResearch UpdatesTop Stories
Mereo and Sentynl Strike Alvelestat Option Deal in Alpha-1 Lung Disease 3 months ago AnaIn Breaking NewsPartnershipsPharma Industry UpdatesResearch UpdatesTop Stories
Coherus Narrows Its Oncology Bet as Cash Discipline Meets Two Phase 2 Readouts 3 months ago AnaIn Clinical TrialsFeatured AnalysisPharma Industry Updates
BeOne Medicines Raises 2026 Outlook as Brukinsa Drives Second-Quarter Growth 3 months ago AnaIn LeadersPharma Industry UpdatesTop Stories
FDA Drug Repurposing Forum Puts Evidence Standards and Patient Access in Focus 3 months ago AnaIn Clinical TrialsFDA ApprovalsFeatured AnalysisPharma Industry Updates
